首页 > 最新文献

Japanese journal of infectious diseases最新文献

英文 中文
Utilizing Infectious Disease Surveillance for Epidemic Warnings of Respiratory Syncytial Virus Infections in Japan from 2015 to 2019. 2015 - 2019年日本呼吸道合胞病毒感染的传染病监测预警
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-03-21 Epub Date: 2024-12-27 DOI: 10.7883/yoken.JJID.2023.484
Akiko Ohta, Shuji Hashimoto, Miyuki Kawado, Mari S Oba, Ritei Uehara, Kiyosu Taniguchi, Tomimasa Sunagawa, Masaki Nagai, Yoshitaka Murakami

Japan's National Epidemiological Surveillance of Infectious Diseases (NESID) has implemented a warning system for detecting epidemics in smaller districts, such as public health center (PHC) areas. This system is applied to influenza and pediatric infectious diseases. Respiratory syncytial virus (RSV) infection is not included but its incorporation is needed for effective early epidemic detection. We aimed to propose criterion values for an epidemic warning system related to RSV infection within PHC areas. We analyzed the weekly number of RSV infection cases reported by sentinel medical institutions (SMIs) in the NESID from 2015 to 2019. Weekly cases per SMI in the PHC area were set to establish an index for epidemic warnings. We determined criteria for issuing an epidemic warning by identifying distribution percentiles within the index. Setting the critical values for the onset and end of the epidemic warning at 5 and 2, respectively, yielded an approximately 5% annual proportion of PHC areas with an epidemic warning, which aligns with previously accepted frequency criteria for epidemic warnings. The 5-year (2015-2019) RSV infection epidemic trend showed that the set critical values were appropriate. Using these values could assist with issuing warnings regarding potential RSV infection epidemics in Japan.

日本国家传染病流行病学监测(NESID)已经实施了一个预警系统,用于在较小的地区,如公共卫生中心(PHC)地区检测流行病。该系统适用于流感和儿童传染病,但不适用于呼吸道合胞病毒(RSV)感染,其纳入是早期发现流行病的必要条件。我们的目的是为PHC地区RSV感染的流行预警系统提出标准值。我们分析了2015 - 2019年NESID哨点医疗机构(SMIs)报告的每周RSV感染病例数。在初级保健地区,每周每例SMI病例被设定为流行病预警指数。我们通过描述指数分布的百分位数来确定发布流行病预警的标准。将流行病警报开始和结束的临界值分别设置为5和2,则产生了大约5%的具有流行病警报的初级保健地区的年比例。这与可接受的流行病警报频率相一致。从5年(2015-2019年)RSV感染流行趋势看,所设定的临界值是合适的。利用这些值可以帮助发布关于日本潜在RSV感染流行的警告。
{"title":"Utilizing Infectious Disease Surveillance for Epidemic Warnings of Respiratory Syncytial Virus Infections in Japan from 2015 to 2019.","authors":"Akiko Ohta, Shuji Hashimoto, Miyuki Kawado, Mari S Oba, Ritei Uehara, Kiyosu Taniguchi, Tomimasa Sunagawa, Masaki Nagai, Yoshitaka Murakami","doi":"10.7883/yoken.JJID.2023.484","DOIUrl":"10.7883/yoken.JJID.2023.484","url":null,"abstract":"<p><p>Japan's National Epidemiological Surveillance of Infectious Diseases (NESID) has implemented a warning system for detecting epidemics in smaller districts, such as public health center (PHC) areas. This system is applied to influenza and pediatric infectious diseases. Respiratory syncytial virus (RSV) infection is not included but its incorporation is needed for effective early epidemic detection. We aimed to propose criterion values for an epidemic warning system related to RSV infection within PHC areas. We analyzed the weekly number of RSV infection cases reported by sentinel medical institutions (SMIs) in the NESID from 2015 to 2019. Weekly cases per SMI in the PHC area were set to establish an index for epidemic warnings. We determined criteria for issuing an epidemic warning by identifying distribution percentiles within the index. Setting the critical values for the onset and end of the epidemic warning at 5 and 2, respectively, yielded an approximately 5% annual proportion of PHC areas with an epidemic warning, which aligns with previously accepted frequency criteria for epidemic warnings. The 5-year (2015-2019) RSV infection epidemic trend showed that the set critical values were appropriate. Using these values could assist with issuing warnings regarding potential RSV infection epidemics in Japan.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"114-117"},"PeriodicalIF":1.3,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in Characteristics, Treatments, and Mortality of Patients with COVID-19 Between 2022 and 2020-2021. 2022年和2020-2021年间COVID-19患者特征、治疗和死亡率的差异。
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-03-21 Epub Date: 2024-11-29 DOI: 10.7883/yoken.JJID.2024.272
Shotaro Aso, Sachiko Ono, Nobuaki Michihata, Kohei Uemura, Hideo Yasunaga

In 2021, vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed and the Omicron variant emerged. This study compared the characteristics, treatments, and mortality of patients with coronavirus disease 2019 (COVID-19) between 2022 and 2020-2021, using administrative claims data linked including vaccine records in a Japanese city. Patients who underwent COVID-19 antigen or polymerase chain reaction tests and were diagnosed with COVID-19 were identified. Patient characteristics, treatments, and mortality were compared between 2022 and 2020-2021 among those diagnosed with COVID-19. We identified 26,262 patients with COVID-19. The mortality in 2022 was lower than that in 2020-2021 (0.6% vs. 1.7%; P < 0.01). Patients in 2022 were significantly less likely to receive oxygen therapy, high-flow nasal oxygenation, mechanical ventilation, steroids, and tocilizumab than those in 2020-2021. Among the deceased, the proportion of those aged ≥65 years was significantly higher in 2022 than in 2020-2021 (98.4% vs. 88.6%). The logistic regression analysis indicated, older age, male sex, and ≥3 comorbidities were associated with higher mortality, whereas ≥3 vaccinations were associated with lower mortality. Patients with COVID-19 in 2022 were less likely to require respiratory care or succumb to the disease. Older patients were more likely to die in 2022 than in 2020-2021.

2021年,针对SARS-CoV-2的疫苗被开发出来,并出现了欧米克隆变体。本研究使用与日本某城市疫苗记录相关的行政索赔数据,比较了2022年至2020-2021年间2019冠状病毒病(COVID-19)患者的特征、治疗和死亡率。我们确定了接受COVID-19抗原或聚合酶链反应试验并被诊断为COVID-19的患者。在2022年至2020-2021年期间,比较了诊断为COVID-19的患者和死亡患者的患者特征、治疗和死亡率。我们确定了26262名COVID-19患者。2022年死亡率低于2020-2021年(0.6% vs. 1.7%;P
{"title":"Differences in Characteristics, Treatments, and Mortality of Patients with COVID-19 Between 2022 and 2020-2021.","authors":"Shotaro Aso, Sachiko Ono, Nobuaki Michihata, Kohei Uemura, Hideo Yasunaga","doi":"10.7883/yoken.JJID.2024.272","DOIUrl":"10.7883/yoken.JJID.2024.272","url":null,"abstract":"<p><p>In 2021, vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed and the Omicron variant emerged. This study compared the characteristics, treatments, and mortality of patients with coronavirus disease 2019 (COVID-19) between 2022 and 2020-2021, using administrative claims data linked including vaccine records in a Japanese city. Patients who underwent COVID-19 antigen or polymerase chain reaction tests and were diagnosed with COVID-19 were identified. Patient characteristics, treatments, and mortality were compared between 2022 and 2020-2021 among those diagnosed with COVID-19. We identified 26,262 patients with COVID-19. The mortality in 2022 was lower than that in 2020-2021 (0.6% vs. 1.7%; P < 0.01). Patients in 2022 were significantly less likely to receive oxygen therapy, high-flow nasal oxygenation, mechanical ventilation, steroids, and tocilizumab than those in 2020-2021. Among the deceased, the proportion of those aged ≥65 years was significantly higher in 2022 than in 2020-2021 (98.4% vs. 88.6%). The logistic regression analysis indicated, older age, male sex, and ≥3 comorbidities were associated with higher mortality, whereas ≥3 vaccinations were associated with lower mortality. Patients with COVID-19 in 2022 were less likely to require respiratory care or succumb to the disease. Older patients were more likely to die in 2022 than in 2020-2021.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"85-90"},"PeriodicalIF":1.3,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142769015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Risk Factors for Severe Japanese Spotted Fever: A Retrospective Multicenter Study in the Nagasaki Prefecture, Western Japan. 严重日本斑疹热的临床特征和风险因素:日本西部长崎县的一项回顾性多中心研究。
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-03-21 Epub Date: 2024-10-31 DOI: 10.7883/yoken.JJID.2024.216
Kohsuke Matsui, Shingo Masuda, Yosuke Koizumi, Monami Yamanaka, Yasumori Izumi, Chris Smith, Reiko Miyahara, Koya Ariyoshi

Japanese spotted fever (JSF) is a tick-borne rickettsial disease prevalent in western Japan with an increasing incidence and geographical distribution. This retrospective study aimed to describe the clinical features of JSF and identify factors associated with its severe form. We included adult patients with laboratory-confirmed JSF in the Nagasaki Prefecture between 2010 and 2021. Severe JSF was defined as an altered mental status, low blood pressure, or low oxygen saturation. In total, 65 JSF cases were diagnosed. Common symptoms included fever (87%), rash (48%), and fatigue (48%), with eschars detected in 50 (79.4%) patients. Thirty-eight (60.3%) patients were initially diagnosed with non-JSF conditions. Twenty-one (33.3%) patients were categorized as having severe JSF, including one death. Prehospital factors associated with severe JSF included age ≥75 (adjusted odds ratio [aOR] 37.53, 95% confidence interval [CI] 3.03-465.38), male sex (aOR 26.5, 95% CI 4.23-166.00), and a treatment delay ≥4 days from onset (aOR 5.96, 95% CI 1.13-31.60). This study highlights the diagnostic challenges of JSF owing to its non-organ-specific clinical presentation. Delayed initial treatment, advanced age, and male sex significantly increase the risk of disease severity. It is crucial to raise awareness of JSF among clinicians and residents in endemic areas.

日本斑疹热(JSF)是一种流行于日本西部的蜱传立克次体疾病,发病率和地理分布都在不断增加。这项回顾性研究旨在描述日本斑疹热的临床特征,并确定与其严重形式相关的因素。我们纳入了 2010 年至 2021 年长崎县实验室确诊的 JSF 成年患者。出现精神状态改变、低血压或低血氧饱和度即为重症 JSF。共诊断出 65 例 JSF。常见症状为发热(87%)、皮疹(48%)和乏力(48%),其中有 50 名患者(79.4%)检测到疱疹。38名患者(60.3%)最初被诊断为非 JSF 病症。21例(33.3%)被归类为严重JSF,其中1例死亡。与重症 JSF 相关的院前因素包括年龄≥75 岁(调整赔率比 [aOR]37.53,95% 置信区间 [CI]3.03-465.38)、性别为男性(aOR 26.5,95% CI 4.23-166.00)和发病后治疗延迟≥4 天(aOR 5.96,95% CI 1.13-31.60)。由于JSF的临床表现无器官特异性,这项研究凸显了JSF在诊断方面的挑战。延迟初始治疗、高龄和男性显著增加了病情严重的风险。进一步提高流行地区临床医生和居民对 JSF 的认识至关重要。
{"title":"Clinical Characteristics and Risk Factors for Severe Japanese Spotted Fever: A Retrospective Multicenter Study in the Nagasaki Prefecture, Western Japan.","authors":"Kohsuke Matsui, Shingo Masuda, Yosuke Koizumi, Monami Yamanaka, Yasumori Izumi, Chris Smith, Reiko Miyahara, Koya Ariyoshi","doi":"10.7883/yoken.JJID.2024.216","DOIUrl":"10.7883/yoken.JJID.2024.216","url":null,"abstract":"<p><p>Japanese spotted fever (JSF) is a tick-borne rickettsial disease prevalent in western Japan with an increasing incidence and geographical distribution. This retrospective study aimed to describe the clinical features of JSF and identify factors associated with its severe form. We included adult patients with laboratory-confirmed JSF in the Nagasaki Prefecture between 2010 and 2021. Severe JSF was defined as an altered mental status, low blood pressure, or low oxygen saturation. In total, 65 JSF cases were diagnosed. Common symptoms included fever (87%), rash (48%), and fatigue (48%), with eschars detected in 50 (79.4%) patients. Thirty-eight (60.3%) patients were initially diagnosed with non-JSF conditions. Twenty-one (33.3%) patients were categorized as having severe JSF, including one death. Prehospital factors associated with severe JSF included age ≥75 (adjusted odds ratio [aOR] 37.53, 95% confidence interval [CI] 3.03-465.38), male sex (aOR 26.5, 95% CI 4.23-166.00), and a treatment delay ≥4 days from onset (aOR 5.96, 95% CI 1.13-31.60). This study highlights the diagnostic challenges of JSF owing to its non-organ-specific clinical presentation. Delayed initial treatment, advanced age, and male sex significantly increase the risk of disease severity. It is crucial to raise awareness of JSF among clinicians and residents in endemic areas.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"63-70"},"PeriodicalIF":1.3,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 IgG Seroprevalence in the Okinawa Main Island and Remote Islands in Okinawa, Japan, 2020-2021. 2020-2021 年日本冲绳本岛和冲绳偏远岛屿的 SARS-CoV-2 IgG 血清流行率。
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-01-23 Epub Date: 2024-09-30 DOI: 10.7883/yoken.JJID.2023.255
Yoshihiro Takayama, Yusuke Shimakawa, Yoshiaki Aizawa, Christian Butcher, Naomi Chibana, Mary Collins, Kohei Kamegai, Tae Gyun Kim, Satoshi Koyama, Ryota Matsuyama, Melissa M Matthews, Tomoari Mori, Tetsuharu Nagamoto, Masashi Narita, Ryosuke Omori, Noriko Shibata, Satoshi Shibata, Souichi Shiiki, Shunichi Takakura, Naoki Toyozato, Hiroyuki Tsuchiya, Matthias Wolf, Taro Yamamoto, Shuhei Yokoyama, Sho Yonaha, Kenji Mizumoto

We estimated the seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) immunoglobulin G (IgG) in different island groups in Okinawa. A cross-sectional serosurvey was conducted over three periods between July 2020 and February 2021. A total of 2,683 serum samples were collected from six referral medical centers, each covering a separate region in Okinawa. In the main island, the seroprevalence was 0.0% (0/392; 95% confidence interval (CI), 0.0- 0.9%), 0.6% (8/1,448, 0.2-1.1%), and 1.4% (8/582, 0.6-2.7%) during the 1st, 2nd, and 3rd serosurvey, respectively. In remote islands, the seroprevalence was 0.0% (0/144; 95% CI, 0.0-2.5%) and 1.6% (2/123, 0.2-5.8%) during the 2nd and 3rd survey, respectively. The case detection ratio was 2.7 (95% CI, 1.3-5.3) in the main island and 2.8 (0.7-11.1) in remote islands during the 3rd survey. The case detection ratio was the highest in individuals aged 20-29 years (8.3; 95% CI, 3.3-21.4) in the main island and in those aged 50-59 years (14.1; 2.1-92.7) in remote islands, suggesting underreporting of clinical cases by the surveillance system in these subgroups. A serosurvey conducted during an emerging infectious disease epidemic can be useful for validating the reliability of the surveillance system by providing case detection ratio.

我们估算了冲绳岛不同岛群抗 SARS-COV-2 IgG 的血清流行率。我们在 2020 年 7 月至 2021 年 2 月期间分三次重复进行了横断面血清调查。共收集了 2683 份血清样本,这些样本分别来自冲绳的六个转诊医疗中心。在本岛,第一次、第二次和第三次血清调查的血清流行率分别为 0.0%(0/392,95% CI:0.0-0.9)、0.6%(8/1448,0.2-1.1)和 1.4%(8/582,0.6-2.7)。在偏远岛屿,第二次和第三次血清调查的血清流行率分别为 0.0%(0/144,95% CI:0.0-2.5)和 1.6%(2/123,0.2-5.8)。在第三次调查中,主岛的病例检出率为 2.7(95% CI:1.3-5.3),偏远岛屿为 2.8(0.7-11.1)。病例检出率在本岛 20-29 岁人群中最高(8.3,95% CI:3.3-21.4),在偏远岛屿 50-59 岁人群中最高(14.1,2.1-92.7),这表明监测系统对这些亚群的临床病例报告不足。在新出现的传染病流行期间进行血清调查可提供病例检出率,有助于验证监测系统的可靠性。
{"title":"SARS-CoV-2 IgG Seroprevalence in the Okinawa Main Island and Remote Islands in Okinawa, Japan, 2020-2021.","authors":"Yoshihiro Takayama, Yusuke Shimakawa, Yoshiaki Aizawa, Christian Butcher, Naomi Chibana, Mary Collins, Kohei Kamegai, Tae Gyun Kim, Satoshi Koyama, Ryota Matsuyama, Melissa M Matthews, Tomoari Mori, Tetsuharu Nagamoto, Masashi Narita, Ryosuke Omori, Noriko Shibata, Satoshi Shibata, Souichi Shiiki, Shunichi Takakura, Naoki Toyozato, Hiroyuki Tsuchiya, Matthias Wolf, Taro Yamamoto, Shuhei Yokoyama, Sho Yonaha, Kenji Mizumoto","doi":"10.7883/yoken.JJID.2023.255","DOIUrl":"10.7883/yoken.JJID.2023.255","url":null,"abstract":"<p><p>We estimated the seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) immunoglobulin G (IgG) in different island groups in Okinawa. A cross-sectional serosurvey was conducted over three periods between July 2020 and February 2021. A total of 2,683 serum samples were collected from six referral medical centers, each covering a separate region in Okinawa. In the main island, the seroprevalence was 0.0% (0/392; 95% confidence interval (CI), 0.0- 0.9%), 0.6% (8/1,448, 0.2-1.1%), and 1.4% (8/582, 0.6-2.7%) during the 1st, 2nd, and 3rd serosurvey, respectively. In remote islands, the seroprevalence was 0.0% (0/144; 95% CI, 0.0-2.5%) and 1.6% (2/123, 0.2-5.8%) during the 2nd and 3rd survey, respectively. The case detection ratio was 2.7 (95% CI, 1.3-5.3) in the main island and 2.8 (0.7-11.1) in remote islands during the 3rd survey. The case detection ratio was the highest in individuals aged 20-29 years (8.3; 95% CI, 3.3-21.4) in the main island and in those aged 50-59 years (14.1; 2.1-92.7) in remote islands, suggesting underreporting of clinical cases by the surveillance system in these subgroups. A serosurvey conducted during an emerging infectious disease epidemic can be useful for validating the reliability of the surveillance system by providing case detection ratio.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"8-18"},"PeriodicalIF":1.3,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of an Outbreak of Clostridium perfringens in Toyama, Japan, 2023 Using Single-Nucleotide Polymorphism Analysis for Genotyping. 利用单核苷酸多态性分析进行基因分型的日本富山梭状芽孢杆菌疫情调查,2023 年。
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-01-23 Epub Date: 2024-09-30 DOI: 10.7883/yoken.JJID.2024.189
Kazuki Saito, Keiko Kimata, Masanori Watahiki, Junko Isobe, Jun-Ichi Kanatani, Kaho Ikeda, Takashi Takeuchi, Chiharu Matsuzaki, Kazunori Oishi

Clostridium perfringens, which produces C. perfringens enterotoxin (CPE), is a major cause of food poisoning because of its gastrointestinal toxicity. In outbreaks of C. perfringens, genotyping is important for identifying the source. We genotyped strains isolated from an outbreak of food poisoning in Toyama Prefecture in 2023, using single-nucleotide polymorphism (SNP) analysis. The strains of C. perfringens were isolated from samples of curry consumed by all the affected patients and from the feces of patients and staff worker. The enterotoxin gene (cpe) was detected in isolates from patients and curry samples. The cpe-negative isolates were found in patients who had consumed curry and in the staff worker. The results of the SNP analysis suggested that the patient and curry isolates were likely from the same source but were unlikely to be related to the staff isolates. The results of SNP and pulsed-field gel electrophoresis (PFGE) analyses were consistent, indicating that the patient and curry isolates originated from the same source. SNP analysis, a whole-genome-based genotyping method, is a promising alternative to traditional PFGE for investigating outbreaks. Further studies are needed to accumulate more experience with genotyping using SNP analysis for the epidemiological investigation of outbreaks of C. perfringens.

产生产气荚膜梭菌肠毒素(CPE)的产气荚膜梭菌因其胃肠道症状而成为食物中毒的主要致病菌。基因分型对于确定产气荚膜梭菌爆发的病原体非常重要。我们尝试利用单核苷酸多态性(SNP)分析对 2023 年富山爆发的食物中毒事件中分离出的菌株进行基因分型。从所有患者食用的咖喱食品以及患者和员工的粪便中分离出了产气荚膜杆菌菌株。从患者和咖喱食品中分离出的菌株都检测到了 cpe 基因。而在食用咖喱食品的患者和雇员体内则发现了 cpe 阴性的分离物。SNP 分析结果表明,患者和咖喱中的分离物可能来自同一来源,但与员工中的分离物不太可能有关联。SNP 分析和脉冲场凝胶电泳 (PFGE) 分析的结果一致,表明患者和咖喱分离物来自同一来源。SNP 分析是一种基于全基因组的基因分型方法,是传统 PFGE 方法的一种很有前途的替代方法。在利用 SNP 分析对产气荚膜杆菌疫情进行流行病学调查方面,还需要进一步的研究来积累更多的基因分型经验。
{"title":"Investigation of an Outbreak of Clostridium perfringens in Toyama, Japan, 2023 Using Single-Nucleotide Polymorphism Analysis for Genotyping.","authors":"Kazuki Saito, Keiko Kimata, Masanori Watahiki, Junko Isobe, Jun-Ichi Kanatani, Kaho Ikeda, Takashi Takeuchi, Chiharu Matsuzaki, Kazunori Oishi","doi":"10.7883/yoken.JJID.2024.189","DOIUrl":"10.7883/yoken.JJID.2024.189","url":null,"abstract":"<p><p>Clostridium perfringens, which produces C. perfringens enterotoxin (CPE), is a major cause of food poisoning because of its gastrointestinal toxicity. In outbreaks of C. perfringens, genotyping is important for identifying the source. We genotyped strains isolated from an outbreak of food poisoning in Toyama Prefecture in 2023, using single-nucleotide polymorphism (SNP) analysis. The strains of C. perfringens were isolated from samples of curry consumed by all the affected patients and from the feces of patients and staff worker. The enterotoxin gene (cpe) was detected in isolates from patients and curry samples. The cpe-negative isolates were found in patients who had consumed curry and in the staff worker. The results of the SNP analysis suggested that the patient and curry isolates were likely from the same source but were unlikely to be related to the staff isolates. The results of SNP and pulsed-field gel electrophoresis (PFGE) analyses were consistent, indicating that the patient and curry isolates originated from the same source. SNP analysis, a whole-genome-based genotyping method, is a promising alternative to traditional PFGE for investigating outbreaks. Further studies are needed to accumulate more experience with genotyping using SNP analysis for the epidemiological investigation of outbreaks of C. perfringens.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"47-50"},"PeriodicalIF":1.3,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of Death in Older Japanese Adults with COVID-19 Caused by the Omicron Variant: a Population-Based Study. 日本 COVID-19 老年病例感染 Omicron 变体的死亡风险:一项基于人群的研究。
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-01-23 Epub Date: 2024-09-30 DOI: 10.7883/yoken.JJID.2024.071
Hideo Tanaka, Yuki Takahashi, Yoshitaka Koga, Shunichi Takiguchi, Shigeru Ogimoto, Shizuyo Inaba, Hiroyuki Matsuoka, Yuka Miyajima, Takeshi Takagi, Fujiko Irie, Yoshihito Bamba, Fuyo Yoshimi, Tomoyuki Suzuki, Isao Araki, Chika Shirai, Sayuri Matsumoto, Toshiyuki Shibata, Hitomi Nagai, Masaru Kinoshita, Rie Fujita, Tsuyoshi Ogata

We assessed case fatality rates (CFRs) in adults aged ≥70 years in 10 prefectures in Japan (14.8 million residents) diagnosed between January 2022 and March 2023, when the Omicron variant was dominant in Japan. We selected incident reports on 283,052 cases from participating public health centers reported according to the Infectious Diseases Control Law. Patients were passively followed up until the end of their isolation, date of death, or 28 days after COVID-19 diagnosis, whichever occurred first. We calculated age-standardized CFRs with 95% confidence intervals (CIs) using the Japanese population aged 70-79, 80-89 and ≥90 years in 2022, divided into 16 subgroups according to the period of COVID-19 diagnosis. The overall CFR was 1.59% (95% CI: 1.55-1.64%); ranging between 0.67% (95% CI: 0.38-0.96%, from May 23 to June 19, 2022) and 2.58% (95% CI: 2.36-2.80%, from January 31 to February 27, 2022). The age-standardized CFRs had three peaks, (2.2% from January 31 to February 27, 2022; 1.0% from July 18 to August 14, 2022; and 1.6% from December 26, 2022 to January 22, 2023) coinciding with the 6th, 7th, and 8th COVID-19 waves in Japan caused by the Omicron variant. Population-based CFRs for Omicron variant COVID-19 in adults aged ≥70 years remained <3% throughout the period January 2022 to March 2023, including during three large waves in Japan.

我们评估了 2022 年 1 月至 2023 年 3 月期间在日本 10 个都道府县(1480 万居民)确诊的年龄≥70 岁病例的病死率(CFR),当时奥米克龙变异体在日本占主导地位。我们从遵守《传染病防治法》的公共卫生中心选取了 283,052 名研究对象的病例报告。我们对病例进行了被动随访,直至其隔离期结束、死亡日期或确诊 COVID-19 后 28 天(以先发生者为准)。我们以 2022 年年龄在 70-79 岁、80-89 岁和≥90 岁的日本人口为研究对象,根据 COVID-19 诊断时间分为 16 个亚组,计算了年龄标准化 CFR 及 95% 置信区间 (CI)。总CFR为1.59%(95% CI 1.55-1.64);介于0.67%(95% CI 0.38-0.96,5月23日至6月19日)和2.58%(95% CI 2.36-2.80,1月31日至2月27日)之间。我们观察到年龄标准化 CFR 的三个峰值与日本由 Omicron 驱动的第 6、7 和 8 次 COVID-19 流行波(分别为 2.2%,1 月 31 日-2 月 27 日;1.0%,7 月 18 日-8 月 14 日;1.6%,12 月 26 日-2023 年 1 月 22 日)相平行。年龄≥70 岁的日本人中 Omicron 变体 COVID-19 的基于人口的 CFR 仍为
{"title":"Risk of Death in Older Japanese Adults with COVID-19 Caused by the Omicron Variant: a Population-Based Study.","authors":"Hideo Tanaka, Yuki Takahashi, Yoshitaka Koga, Shunichi Takiguchi, Shigeru Ogimoto, Shizuyo Inaba, Hiroyuki Matsuoka, Yuka Miyajima, Takeshi Takagi, Fujiko Irie, Yoshihito Bamba, Fuyo Yoshimi, Tomoyuki Suzuki, Isao Araki, Chika Shirai, Sayuri Matsumoto, Toshiyuki Shibata, Hitomi Nagai, Masaru Kinoshita, Rie Fujita, Tsuyoshi Ogata","doi":"10.7883/yoken.JJID.2024.071","DOIUrl":"10.7883/yoken.JJID.2024.071","url":null,"abstract":"<p><p>We assessed case fatality rates (CFRs) in adults aged ≥70 years in 10 prefectures in Japan (14.8 million residents) diagnosed between January 2022 and March 2023, when the Omicron variant was dominant in Japan. We selected incident reports on 283,052 cases from participating public health centers reported according to the Infectious Diseases Control Law. Patients were passively followed up until the end of their isolation, date of death, or 28 days after COVID-19 diagnosis, whichever occurred first. We calculated age-standardized CFRs with 95% confidence intervals (CIs) using the Japanese population aged 70-79, 80-89 and ≥90 years in 2022, divided into 16 subgroups according to the period of COVID-19 diagnosis. The overall CFR was 1.59% (95% CI: 1.55-1.64%); ranging between 0.67% (95% CI: 0.38-0.96%, from May 23 to June 19, 2022) and 2.58% (95% CI: 2.36-2.80%, from January 31 to February 27, 2022). The age-standardized CFRs had three peaks, (2.2% from January 31 to February 27, 2022; 1.0% from July 18 to August 14, 2022; and 1.6% from December 26, 2022 to January 22, 2023) coinciding with the 6th, 7th, and 8th COVID-19 waves in Japan caused by the Omicron variant. Population-based CFRs for Omicron variant COVID-19 in adults aged ≥70 years remained <3% throughout the period January 2022 to March 2023, including during three large waves in Japan.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"1-5"},"PeriodicalIF":1.3,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Diversity and Potential Transmission of Escherichia albertii in a Poultry-Breeding Rural Village. 一个家禽养殖农村的白细胞埃希氏菌遗传多样性和潜在传播途径。
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-01-23 Epub Date: 2024-09-30 DOI: 10.7883/yoken.JJID.2024.209
Peihua Zhang, Guodong Yan, Qian Liu, Xi Yang, Jie Zhang, Xi Chen, Hong Wang, Ling Zhang, Xinxia Sui, Xiangning Bai, Yanwen Xiong, Zhengdong Zhang

Escherichia albertii is an emerging foodborne pathogen that causes diarrhea. Although various animals, especially poultry, serve as reservoirs of E. albertii, the transmission of E. albertii among reservoirs and the associated risks to humans remain unclear. This study investigated an E. albertii-infected infant exposed to poultry, and collected samples from contact persons, poultry, and the environment to better understand the transmission dynamics of E. albertii. One E. albertii isolate from a contact person, seven isolates from poultry, and six isolates from the environment were recovered. Whole-genome sequencing analysis showed that eight strains derived from poultry or environment and classified as ST4633 shared great similarity (core genome single-nucleotide polymorphisms [cgSNPs] ≤20). However, the patient-derived strain ESA311 had a cgSNP difference of 1165 with the human strain ESA339 and differed from poultry and environmental strains (cgSNP range 2417-14997), indicating distant relatedness. The whole-genome phylogeny showed that several human-derived E. albertii strains clustered with those of animal origin. Our results suggest that family-bred poultry constitute a possible reservoir for E. albertii, with the environment acting as a crucial vector for the spread of these bacteria and posing a risk to humans. Further surveillance of poultry is required to elucidate the public health risks associated with E. albertii infections.

白喉杆菌是一种新出现的食源性病原体,可引起腹泻。虽然各种动物(尤其是家禽)都是白喉杆菌的宿主,但白喉杆菌在宿主之间的传播以及对人类的风险仍不清楚。本研究调查了一名因接触家禽而感染白喉杆菌的婴儿,并从接触者、家禽饲养场和环境中采集样本,以更好地了解白喉杆菌的传播动态。研究分别从接触者、家禽饲养场和环境中分离出了 1 株白喉杆菌、7 株和 6 株。全基因组测序分析表明,8 株来自家禽或环境的菌株被归类为 ST4633,它们具有很大的相似性(cgSNP ≤ 20)。然而,患者来源的菌株ESA311与人类菌株ESA339的cgSNP相差1165,与家禽和环境菌株的cgSNP范围(2417至14997)不同,这表明两者之间存在远缘关系。全基因组系统发育显示,一些来自人类的白喉杆菌菌株与来自动物的菌株聚集在一起。我们的研究结果表明,家庭饲养的家禽可能是白喉杆菌的贮藏库,环境是这些细菌传播的重要媒介,对人类构成风险。需要对家禽进行进一步监测,以阐明与白喉杆菌感染相关的公共卫生风险。
{"title":"Genetic Diversity and Potential Transmission of Escherichia albertii in a Poultry-Breeding Rural Village.","authors":"Peihua Zhang, Guodong Yan, Qian Liu, Xi Yang, Jie Zhang, Xi Chen, Hong Wang, Ling Zhang, Xinxia Sui, Xiangning Bai, Yanwen Xiong, Zhengdong Zhang","doi":"10.7883/yoken.JJID.2024.209","DOIUrl":"10.7883/yoken.JJID.2024.209","url":null,"abstract":"<p><p>Escherichia albertii is an emerging foodborne pathogen that causes diarrhea. Although various animals, especially poultry, serve as reservoirs of E. albertii, the transmission of E. albertii among reservoirs and the associated risks to humans remain unclear. This study investigated an E. albertii-infected infant exposed to poultry, and collected samples from contact persons, poultry, and the environment to better understand the transmission dynamics of E. albertii. One E. albertii isolate from a contact person, seven isolates from poultry, and six isolates from the environment were recovered. Whole-genome sequencing analysis showed that eight strains derived from poultry or environment and classified as ST4633 shared great similarity (core genome single-nucleotide polymorphisms [cgSNPs] ≤20). However, the patient-derived strain ESA311 had a cgSNP difference of 1165 with the human strain ESA339 and differed from poultry and environmental strains (cgSNP range 2417-14997), indicating distant relatedness. The whole-genome phylogeny showed that several human-derived E. albertii strains clustered with those of animal origin. Our results suggest that family-bred poultry constitute a possible reservoir for E. albertii, with the environment acting as a crucial vector for the spread of these bacteria and posing a risk to humans. Further surveillance of poultry is required to elucidate the public health risks associated with E. albertii infections.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"19-27"},"PeriodicalIF":1.3,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemotactic Activity of Products of Elizabethkingia anophelis Derived from Aedes albopictus against RAW264 Murine Macrophage Cell Line. 从白纹伊蚊中提取的 Elizabethkingia anophelis 产品对 RAW264 鼠巨噬细胞系的趋化活性。
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-01-23 Epub Date: 2024-10-31 DOI: 10.7883/yoken.JJID.2024.227
Satoru Yui, Norihiko Fujii, Jo Terauchi, Nana Tanabe, Marie Kanno, Kouta Umehara, Ryosuke Iijima, Riyo Kamata, Naoki Ohkura, Seishi Kishimoto, Toshinori Sasaki

Dengue viruses enter the dermal macrophages derived from other tissues following a bite from an infected mosquito. We examined the chemotactic activity of factors derived from the dengue vector mosquito Aedes albopictus on a RAW264 murine macrophage cell line. We found that Elizabethkingia anophelis isolated from the mosquitoes exhibits migration-inducing activity in RAW264 cells. The active substances that induce the chemotactic movement were extracted using ethyl acetate. Chemotactic activity was noted in several of the fractions isolated using reverse-phase chromatography, suggesting that multiple components were responsible for this activity. Next, we isolated three bacterial colonies from wild A. albopictus mosquitoes collected from Toyama Park (Tokyo, Japan). The bacterial 16S rRNA gene sequences shared homology with that of Lonsdalea quercina. These bacteria also exhibited migration-inducing activity in RAW264 cells. The migration-inducing activity of the bacteria in mosquitoes may be a novel aspect of mosquito-mediated viral infections.

登革热病毒会进入皮肤巨噬细胞,而巨噬细胞来自蚊子叮咬后的其他组织。我们研究了登革热病媒蚊子白纹伊蚊对 RAW264 小鼠巨噬细胞系的趋化因子。我们发现,从蚊子体内分离出来的伊丽莎白金丝楠对 RAW264 细胞具有迁移诱导活性。使用乙酸乙酯提取活性物质以诱导趋化运动。使用反相色谱法在多个馏分中都能洗脱出趋化活性,这表明该活性是由多种物质引起的。我们从日本东京都富山公园采集的野生白纹伊蚊中分离出三个细菌菌落。细菌的 16S rRNA 基因序列与 Lonsdalea quercina 最为相似。这些细菌对 RAW264 细胞也具有迁移诱导活性。蚊子细菌的迁移诱导活性可能是蚊子介导的病毒感染的一个新方面。
{"title":"Chemotactic Activity of Products of Elizabethkingia anophelis Derived from Aedes albopictus against RAW264 Murine Macrophage Cell Line.","authors":"Satoru Yui, Norihiko Fujii, Jo Terauchi, Nana Tanabe, Marie Kanno, Kouta Umehara, Ryosuke Iijima, Riyo Kamata, Naoki Ohkura, Seishi Kishimoto, Toshinori Sasaki","doi":"10.7883/yoken.JJID.2024.227","DOIUrl":"10.7883/yoken.JJID.2024.227","url":null,"abstract":"<p><p>Dengue viruses enter the dermal macrophages derived from other tissues following a bite from an infected mosquito. We examined the chemotactic activity of factors derived from the dengue vector mosquito Aedes albopictus on a RAW264 murine macrophage cell line. We found that Elizabethkingia anophelis isolated from the mosquitoes exhibits migration-inducing activity in RAW264 cells. The active substances that induce the chemotactic movement were extracted using ethyl acetate. Chemotactic activity was noted in several of the fractions isolated using reverse-phase chromatography, suggesting that multiple components were responsible for this activity. Next, we isolated three bacterial colonies from wild A. albopictus mosquitoes collected from Toyama Park (Tokyo, Japan). The bacterial 16S rRNA gene sequences shared homology with that of Lonsdalea quercina. These bacteria also exhibited migration-inducing activity in RAW264 cells. The migration-inducing activity of the bacteria in mosquitoes may be a novel aspect of mosquito-mediated viral infections.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"35-42"},"PeriodicalIF":1.3,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory Syncytial Virus Infection Notification Trends and Interpretation of the Reported Case Data, 2018-2021, Japan. 2018-2021 年日本呼吸道合胞病毒感染通报趋势及病例报告数据解读。
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-01-23 Epub Date: 2024-09-30 DOI: 10.7883/yoken.JJID.2024.187
Miyako Otsuka, Ayu Kasamatsu, Yuzo Arima, Takuri Takahashi, Takeshi Arashiro, Katsuhiro Komase, Reiko Shimbashi, Yuuki Tsuchihashi, Yusuke Kobayashi, Osamu Takahara, Kazuhiko Kanou, Motoi Suzuki

In Japan, as elsewhere, the coronavirus disease 2019 (COVID-19) pandemic has affected notification trends of respiratory syncytial virus (RSV) infection. Here, we describe the epidemiological trends of cases of RSV infection among children reported during 2018-2021 in Japan based on the national surveillance system. Compared with 2018 and 2019, 2020 saw an unprecedented decrease in notifications of RSV infection per sentinel site. However, 2021 experienced an unseasonably early and high peak at week 28 (peak week in 2018 and 2019 was week 37), with a large resurgence in notifications nationwide and across regions. Regarding age, compared with 2018 and 2019, the number and proportion of case-patients aged 2, 3, and ≥4-years increased substantially in 2021, but the number of case-patients aged <1 year decreased slightly. Furthermore, in 2021, the ratio of notifications per site from outpatient clinics to notifications per site from hospitals increased, suggesting a proportionate increase in diagnoses of clinically milder cases. Notably, RSV-attributed deaths from vital statistics also dropped substantially in 2020 and rebounded in 2021 but were fewer than in 2018 or 2019. While the incidence of RSV infections likely declined in 2020 (possibly owing to COVID-19 countermeasures) and increased in 2021, notifications in 2021 appeared to be associated with milder presentations. Given the unpredictable epidemiology of RSV, continuous monitoring and pluralistic assessments are imperative.

与其他地方一样,日本的 COVID-19 大流行也影响了呼吸道合胞病毒(RSV)感染的通报趋势。在此,我们根据国家监测系统描述了 2018-2021 年期间日本报告的儿童 RSV 病例的流行病学趋势。与 2018 年和 2019 年相比,2020 年每个哨点的 RSV 报告数量出现了前所未有的下降。然而,2021 年在第 28 周出现了一个反常的早期高峰(2018 年和 2019 年的高峰周:第 37 周),全国和各地区的通报数大幅回升。在年龄方面,与 2018 年和 2019 年相比,2021 年 2 岁、3 岁和≥4 岁病例的数量和比例大幅增加,但年龄在≥4 岁的病例数量和比例则有所下降。
{"title":"Respiratory Syncytial Virus Infection Notification Trends and Interpretation of the Reported Case Data, 2018-2021, Japan.","authors":"Miyako Otsuka, Ayu Kasamatsu, Yuzo Arima, Takuri Takahashi, Takeshi Arashiro, Katsuhiro Komase, Reiko Shimbashi, Yuuki Tsuchihashi, Yusuke Kobayashi, Osamu Takahara, Kazuhiko Kanou, Motoi Suzuki","doi":"10.7883/yoken.JJID.2024.187","DOIUrl":"10.7883/yoken.JJID.2024.187","url":null,"abstract":"<p><p>In Japan, as elsewhere, the coronavirus disease 2019 (COVID-19) pandemic has affected notification trends of respiratory syncytial virus (RSV) infection. Here, we describe the epidemiological trends of cases of RSV infection among children reported during 2018-2021 in Japan based on the national surveillance system. Compared with 2018 and 2019, 2020 saw an unprecedented decrease in notifications of RSV infection per sentinel site. However, 2021 experienced an unseasonably early and high peak at week 28 (peak week in 2018 and 2019 was week 37), with a large resurgence in notifications nationwide and across regions. Regarding age, compared with 2018 and 2019, the number and proportion of case-patients aged 2, 3, and ≥4-years increased substantially in 2021, but the number of case-patients aged <1 year decreased slightly. Furthermore, in 2021, the ratio of notifications per site from outpatient clinics to notifications per site from hospitals increased, suggesting a proportionate increase in diagnoses of clinically milder cases. Notably, RSV-attributed deaths from vital statistics also dropped substantially in 2020 and rebounded in 2021 but were fewer than in 2018 or 2019. While the incidence of RSV infections likely declined in 2020 (possibly owing to COVID-19 countermeasures) and increased in 2021, notifications in 2021 appeared to be associated with milder presentations. Given the unpredictable epidemiology of RSV, continuous monitoring and pluralistic assessments are imperative.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"51-54"},"PeriodicalIF":1.3,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of Prognosis in Patients with Severe Fever with Thrombocytopenia Syndrome. 预测严重发热伴血小板减少综合征患者的预后。
IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES Pub Date : 2025-01-23 Epub Date: 2024-09-30 DOI: 10.7883/yoken.JJID.2024.015
Yi Zhang, Lingtong Huang, Zheyue Shu, Wei Wu, Hongliu Cai, Yu Shi

This study aimed to understand the clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) and identify the risk factors for prognosis. In this retrospective study, we collected epidemiological, demographic, clinical, and laboratory data from 101 patients with SFTS. Patients were divided into survival and deceased groups, and a logistic regression model was used to evaluate the association between the predictors and prognostic variables. A joint detection factor model was constructed, and a receiver operating characteristic curve was drawn. A nomogram was established using the R language, and its efficiency in diagnosing SFTS was evaluated using a calibration curve. Patients in the deceased group were more likely to be older, have a shorter hospitalization stay, and have renal and multiple organ failure than those in the survival group. Statistically significant differences were observed in the neutrophil percentage, lymphocyte percentage, neutrophil-to-lymphocyte ratio, platelet (PLT) count, aspartate aminotransferase (AST)/alanine transaminase (ALT) ratio, AST, blood urea nitrogen, lactate dehydrogenase, hydroxybutyrate dehydrogenase, thromboplastin time, and activated partial thromboplastin time between the two groups. Lymphocyte percentage, PLT count, and the AST/ALT ratio were independent risk factors for mortality in patients with SFTS. Thus, we established a prediction model for SFTS mortality with good efficiency.

本研究旨在了解严重发热伴血小板减少综合征(SFTS)的临床特征,并筛查预后的危险因素。这项回顾性研究收集了101名严重发热伴血小板减少综合征患者的流行病学、人口统计学、临床和实验室数据。将患者分为存活组和死亡组,然后使用逻辑回归模型评估预测因素与预后变量之间的关联。建立了联合检测因子模型,并绘制了接收者操作特征曲线(ROC)。使用 R 语言建立了一个提名图,并使用校准曲线评估了其在诊断 SFTS 中的效率。与存活组相比,死亡组患者的年龄更大、住院时间更短、肾功能衰竭和多器官功能衰竭的可能性更大。两组患者的中性粒细胞百分比、淋巴细胞百分比、中性粒细胞与淋巴细胞比率、血小板(PLT)、谷草转氨酶、谷草转氨酶/谷丙转氨酶、血尿素氮、乳酸脱氢酶、羟丁酸脱氢酶、凝血活酶时间和活化部分凝血活酶时间存在统计学差异。淋巴细胞百分比、PLT 和 AST/ALT 是 SFTS 患者死亡的独立风险因素。我们建立了一个有效的 SFTS 死亡率预测模型。
{"title":"Prediction of Prognosis in Patients with Severe Fever with Thrombocytopenia Syndrome.","authors":"Yi Zhang, Lingtong Huang, Zheyue Shu, Wei Wu, Hongliu Cai, Yu Shi","doi":"10.7883/yoken.JJID.2024.015","DOIUrl":"10.7883/yoken.JJID.2024.015","url":null,"abstract":"<p><p>This study aimed to understand the clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) and identify the risk factors for prognosis. In this retrospective study, we collected epidemiological, demographic, clinical, and laboratory data from 101 patients with SFTS. Patients were divided into survival and deceased groups, and a logistic regression model was used to evaluate the association between the predictors and prognostic variables. A joint detection factor model was constructed, and a receiver operating characteristic curve was drawn. A nomogram was established using the R language, and its efficiency in diagnosing SFTS was evaluated using a calibration curve. Patients in the deceased group were more likely to be older, have a shorter hospitalization stay, and have renal and multiple organ failure than those in the survival group. Statistically significant differences were observed in the neutrophil percentage, lymphocyte percentage, neutrophil-to-lymphocyte ratio, platelet (PLT) count, aspartate aminotransferase (AST)/alanine transaminase (ALT) ratio, AST, blood urea nitrogen, lactate dehydrogenase, hydroxybutyrate dehydrogenase, thromboplastin time, and activated partial thromboplastin time between the two groups. Lymphocyte percentage, PLT count, and the AST/ALT ratio were independent risk factors for mortality in patients with SFTS. Thus, we established a prediction model for SFTS mortality with good efficiency.</p>","PeriodicalId":14608,"journal":{"name":"Japanese journal of infectious diseases","volume":" ","pages":"28-34"},"PeriodicalIF":1.3,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Japanese journal of infectious diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1